In the first comprehensive evidence-based guideline on the use of fecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends fecal ...

Fecal microbiota transplant was noninferior to vancomycin as the initial treatment for C. diff in a randomized, open-label trial. Transplant showed slightly higher cure rates without recurrence and ...

Fecal microbiota transplantation (FMT) for Parkinson's disease (PD) is safe but does not offer clinically meaningful improvement in symptoms, results of a new, randomized placebo-controlled trial show ...

Fecal microbiota transplants are the most effective and affordable treatment for recurrent infections with Clostridioides difficile, an opportunistic bacterium and the most common cause of ...

Please provide your email address to receive an email when new articles are posted on . Fecal microbiota transplant from healthy donors may lower primary resistance to immunotherapy with anti-PD-1 ...

Please provide your email address to receive an email when new articles are posted on . “FMT homebrew is a fecal microbiota transplant that is performed at home,” Paul Feuerstadt, MD, FACG, AGAF, ...

Saffron Cassaday, right, pictured with her husband and stool donor, Al Mukadam. Cassaday did fecal microbiota transplantation, which involves transferring stool from a healthy donor to a patient to ...

Diarrhea in foals is fairly common, but it can lead to life-threatening complications such as systemic infections. Causes for diarrhea in foals are varied, but can be associated with reduced bacterial ...

A meta-analysis of randomized trials suggests fecal microbiota transplantation can ease depressive symptoms, with stronger effects reported for endoscopic or enema delivery, according to researchers ...

A single fecal microbiota transplant in obese teens was linked to long-lasting metabolic improvements, including smaller waistlines, reduced body fat, lower inflammation, and better cholesterol levels ...

Fecal microbiota transplant might be considered for first-line treatment of Clostridioides difficile (C. diff), based on noninferiority findings from a randomized, open-label trial. A similar ...